Money raised in the round came through the sale of 2.4 million shares of its common stock at a price of $1.80 per share, the New York City-based company said.
The offering also includes a 45-day underwriter’s option to purchase an additional 362,292 shares of common stock to cover any overallotments, Pavmed said.
Dawson James Securities acted as the sole underwriter for the offering.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!